Downloads

  1. Europe's ATMP Opportunity Still Requires Local Navigation 8/27/2026

    European nations offer a welcoming environment for clinical-phase cell and gene therapies. Don't assume the same flexibility carries through to commercialization.

  2. The Unspoken Truth About Cell Therapy Product Understanding 8/27/2026

    Developers often discover important attributes after it's too late to act on them. A well-designed program asks what's needed for commercialization and works backward.

  3. How To Define, Monitor, And Hit Critical Endpoints 8/26/2026

    Improve UF/DF repeatability by defining clear concentration and diafiltration endpoints, matching them with appropriate measurements, and applying real-time in-line analytics to reduce variability.

  4. Improving Screening Workflows For 3D Applications 8/26/2026

    New approaches to whole-sample imaging and quantitative fluorescence analysis are enabling more reliable screening of 3D models. Learn how researchers can generate more reproducible longitudinal data.

  5. A Comprehensive Solution With Targeted And Non-Targeted Approaches 8/26/2026

    Explore how non-targeted NGS and targeted molecular assays can work together during cell line characterization to provide broad virus detection while supporting evolving regulatory expectations.

  6. What Our Partners Achieve With P. fluorescens-Based Expression Technology 8/26/2026

    When E. coli, CHO, and yeast fall short on titer, protein quality, or scalability, a P. fluorescens-based expression platform built on 25 years of strain engineering offers a different path.

  7. Enzyme Activity As A Surrogate Potency Marker In Cell Therapy 8/26/2026

    When measuring cell therapy potency, biochemical assays can provide a rapid alternative to the time- and material-consuming standard of cell-based assays.

  8. Characterizing Process Performance And Robustness In An End-To-End Cryopreserved Autologous CAR-T/TCR Workflow 8/25/2026

    A systematic evaluation of an end-to-end cryopreserved CAR-T workflow examines how critical process parameters and unit operation interdependencies affect manufacturing consistency and robustness.

  9. Driving Measurable Productivity Gains In CHO Cell Culture 8/25/2026

    Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.

  10. Implementing And Optimizing Your eQMS 8/25/2026

    This article addresses everything that follows the signed contract for an eQMS: how a system is configured, validated, adopted, and maintained.